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Abstract
Background: Eukaryotic translation initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF) and a
key regulator of translation initiation under normal and stress conditions, causes an autosomal recessive
leukodystrophy of a wide clinical spectrum. EBV-immortalised lymphocytes (EIL) from eIF2B-mutated patients
exhibit a decrease in eIF2B GEF activity. eIF2B-mutated primary fibroblasts have a hyper-induction of activating
transcription factor 4 (ATF4) which is involved in the protective unfolded protein response (UPR), also known as
the ER-stress response. We tested the hypothesis that EIL from eIF2B-mutated patients also exhibit a heightened
ER-stress response.
Methods: We used thapsigargin as an ER-stress agent and looked at polysomal profiles, rate of protein synthesis,
translational activation of ATF4, and transcriptional induction of stress-specific mRNAs (ATF4, CHOP, ASNS, GRP78) in
normal and eIF2B-mutated EIL. We also compared the level of stress-specific mRNAs between EIL and primary
lymphocytes (PL).
Results: Despite the low eIF2B GEF activity in the 12 eIF2B-mutated EIL cell lines tested (range 40-70% of normal),
these cell lines did not differ from normal EIL in their ATF4-mediated ER-stress response. The absence of hyper-
induction of ATF4-mediated ER-stress response in eIF2B-mutated EIL in contrast to primary fibroblasts is not related
to their transformation by EBV. Indeed, PL exhibited a higher induction of the stress-specific mRNAs in comparison
to EIL, but no hyper-induction of the UPR was noticed in the eIF2B-mutated cell lines in comparison to controls.
Conclusions: Taken together with work of others, our results demonstrate the absence of a major difference in ER-
stress response between controls and eIF2B-mutated cells. Therefore, components of the ER-stress response cannot
be used as discriminantory markers in eIF2B-related disorders.
Background
The eukaryotic initiation factor 2B (eIF2B) is a ubiqui-
tously expressed protein with guanine nucleotide
exchange factor (GEF) activity that is involved in the
translation initiation step by activating the eIF2 factor.
Mutations in any one of the EIF2B1-5 genes [Swiss-
Prot: Q14232, P49770, Q9NR50, Q9UI10, Q13144],
encoding the five eIF2B subunits, have been initially
described in an autosomal recessive form of inherited
disorders, the childhood ataxia with central hypomyeli-
nation (CACH)/Vanishing white matter (VWM) syn-
drome [1-4]. This leukoencephalopathy is characterized
in infants by a progressive neurological deterioration
exacerbated by episodes of stress and a cerebrospinal
fluid (CSF)-like signal intensity of the WM on brain
magnetic resonance imaging (MRI) [1,2]. The use of a
typical MRI pattern to select patients with undetermined
leukodystrophies for EIF2B1-5 genes analysis demon-
strated the wide clinical spectrum of eIF2B-mutated
patients from congenital and rapidly lethal forms to
slowly progressive or even asymptomatic adult forms
associated in some cases with ovarian failure [5,6]. The
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need for a reliable and quick diagnostic marker, useful
to select patients eligible for EIF2B1-5 sequencing
became obvious.
eIF2B is a key regulator of the translation initiation
step by its nucleotide guanine exchange activity (GEF
activity) that converts the eIF2 factor from an inactive
GDP-bound form to an active GTP-bound form fol-
lowed by initiation of the first step of the translation
process. We previously reported a decrease eIF2B GEF
activity in Epstein-Barr virus (EBV)-immortalised lym-
phocytes (EIL, or lymphoblasts) from patients with
eIF2B-related disorder that seemed to correlate with dis-
ease severity [7]. eIF2B GEF activity is subjected to
diverse modes of regulation. One of the inhibitory
mechanisms is mediated by phosphorylation of Ser 51
of eIF2a subunit by four specific kinases (PERK, GCN2,
PKR and HRI), each of which is activated by specific
stress conditions including endoplasmic reticulum (ER)-
stress [8]. eIF2 phosphorylation mediates the inhibition
of eIF2B, leading to reduction of global translation
initiation which is accompanied by translational activa-
tion of specific sub-class of mRNAs encoding rescue
proteins. One example is translational induction of the
mRNA encoding activating transcription factor 4
(ATF4) under stress conditions.
ATF4-mediated heightened stress response was
demonstrated in several eIF2B-mutated models [9-16].
In yeast, it has been shown that eIF2B mutations induce
a decrease of eIF2B GEF activity, leading to the transla-
tion activation of GCN4 mRNA, the yeast homolog of
ATF4 involved in stress regulation [10,11]. Later on,
heightened ER-stress response mediated by hyper-induc-
tion of ATF4 was observed in primary fibroblasts from
eIF2B-mutated patients [9], and in rat oligodendroglial-
derived cells expressing mutated human EIF2B5 gene
[12]. Similarly, increased levels of ER-stress markers
were detected in cerebral white matter from eIF2B-
mutated patients [13,14]. Surprisingly, although eIF2B
mutations render the mutated cells hyper-sensitive to
stress, eIF2B GEF activity was not significantly decreased
in most of the above mentioned cell types. The only
human cell lines exhibiting a measurable decrease of
eIF2B GEF activity were lymphoblasts from eIF2B-
mutated patients [7,16]. A single study reported stress-
related differences between control and eIF2B-mutated
patient’s EIL: mutated EIL lost their ability to respond
to heat stress by eIF2a phosphorylation, suggesting a
lack of inhibition of eIF2B GEF activity under stress
conditions [17] leading to a potentially disturbed cellular
response.
In the current study, we tested the hypothesis that EIL
from eIF2B-mutated patients would also express a
heightened ER-stress response that would be useful in
understanding the mechanism of the disease. For this
purpose, we compared the effect of ER-stress on eIF2B-
mutated and control EIL by looking at i) polysomal
profiles; ii) rate of protein synthesis; iii) translational
induction of ATF4 mRNA; and iv) transcriptional induc-
tion of mRNA encoding ATF4, C/EBP-Homologous
Protein (CHOP), Asparagine synthetase (ASNS) and
Glucose-Regulated protein 78 kDa (GRP78).
Methods
Selection of patients and generation of lymphoblasts
Fourteen eIF2B-mutated patients from 13 affected
families were selected according to age at disease onset
(from age 0.8 to 16 years) and type of eIF2B mutations
(Table 1) [16], in comparison to nine age- and sex-
matched healthy patients used as controls. An Institu-
tional Review Board of the participating centers (Comité
de Protection des Personnes Sud-Est VI, 2009-A00188-
49) approved the use of human subjects for this study.
A written informed consent was obtained from all
patients.
Patients’ lymphocytes (PL) were immortalized with the
Epstein-Barr virus (EBV) according to classical proce-
dures [18].
Twelve eIF2B-mutated EIL were used to compare the
protein and transcript expression after ER-stress, in
comparison to six associated control EIL. PL and EIL
from four eIF2B-mutated patients (Table 1) were used
to analyze the impact of PL immortalization on the
transcript ER-stress response, in comparison to PL and
EIL from three healthy controls (C1, C2, 1283-1).
eIF2B GEF activity
The GEF activity of eIF2B was measured in triplicate as
previously described [7].
ER-stress induction
Patients’ EIL and PL were incubated with 0.5, 1 or 2 μg/
ml Thapsigargin (Tg) for 4 h or 1.5 h at 37°C, harvested
just after the treatment or submitted to recovery for 1
h, 3 h, 6 h, 12 h, 15 h, 18 h or 24 h under normal.
Global protein synthesis rate and polysomal profiles
Global protein synthesis rates were determined as
described previously [19] by using EIL incubated in the
absence or presence of 2 μg/ml Tg for 1 hour for label-
ing with [35S]L-methionine/[35S]L-cysteine mix for 20
min. Polysomal profiles were performed on 0-50%
sucrose gradients according to Sivan et al. [19] using 1
× 107 EIL per gradient.
Immunodetection of ATF4
Western blot analysis of ATF4 was performed as pre-
viously described [9] using EIL, incubated in the absence
or presence of 2 μg/ml Tg for 4 hours.
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Quantitative Real-Time Polymerase Chain Reaction (QRT-
PCR)
Total RNA was extracted from pellets of 15.106 cells
using TRIZOL solution (Invitrogen Life Technology)
according to classical procedures. One μg RNA was sub-
jected to RT, performed in duplicate, with 0.5 mM
dNTP, 0.025 μg/μl oligodT, 1× First Strand Buffer, 10
mM DTT, 40 U Rnase Out and 200 U SuperScript™III
Rnase H-Reverse Transcriptase (Invitrogen) at 42°C dur-
ing 1 h then 70°C during 15 min. Quantitations of
ATF4, CHOP, ASNS, GRP78 and b2-microglobulin
(B2M) mRNA levels were carried-out in duplicate on
Light Cycler (Roche) using the SybrGreen technology
and the specific set of primers: ATF4-F: 5′-CCCC
TTCACCTTCTTACAACC-3′; ATF4-R: 5′-GGGCTCA
TACAGATGCCACAT-3′; CHOP-F: 5′-CAGAACCAG
CAGAGGTCACA 3′; CHOP-R: 5′-AGCTGTGCCAC
TTTCCTTTC-3′; GRP78-F: 5′-GGTTGATTATCAGA
AGCTGTAG-3′; GRP78-R: 5′-CGTATGGTGCTGCT
GTCCAGG-3′; ASNS-F: 5′-ATCACTGTCGGGAT-
GAACCC-3′; ASNS-R: 5′-CTTCAACAGAGTGGCAG-
CAA-3′; B2M-F: 5′-TGTCTTTCAGCAAGGACTGG-3′;
B2M-R: 5′-TTCTCTGCTCCCCACCTCTA-3′. One μl of
1:10 cDNA dilution was amplified with 1× LightCycler
FastStart Reaction Mix (Roche), 3 mM MgCl2 and 0.5
mM of each primer in a final volume of 15 μl. The pro-
gram included an initial denaturation (95°C, 10 min) fol-
lowed by 45 cycles of 95°C for 10 seconds, 60°C for 30
seconds and 72°C for 30 seconds. The cycle of threshold
value (Ct) was used to calculate the relative expression
of the genes of interest ATF4, CHOP, ASNS or GRP78,
normalized to b2M.
Results
Effects of eIF2B mutations on eIF2B GEF activity and on
the translation rates in lymphoblasts
eIF2B GEF activities measured in the 12 eIF2B-mutated
EIL were significantly lower (range 40%-78% of normal)
in comparison to the six controls. However, the transla-
tional machineries of both normal and mutated EIL
were inhibited to the same extent by the presence of the
ER-stress agent, as judged by the incorporation rate of
[35S]L-methionine/[35S]L-cysteine which was reduced to
40 ± 5% or 39 ± 3% for patients or control EIL, respec-
tively; and by the similar decrease in heavy polysomes
(data not shown).
These results demonstrate the absence of significant
effect of eIF2B mutations on the intensity of the ER-
stress response despite decrease eIF2B GEF activity.
Effects of eIF2B mutations on the ER-stress response
mediated by ATF4 in lymphoblasts
Next, we evaluated the impact of stress response by
measuring ATF4 protein level in EIL incubated for 4
hours in the presence or absence of 2 μg/ml Tg. As
expected, an increase in ATF4 protein expression was
found under ER-stress conditions (Figure 1A). However,
no differences were observed between controls and
eIF2B-mutated EIL, in ATF4 basal levels and ATF4
induced upon ER-stress. In the Tg-treated EIL, an
Table 1 List of the eIF2B-mutated patients selected for this study
Patients’ number DNA mutation (mutated gene) Protein mutation GEF activity (%)
569-3 c.338G > A/c.766-1G > A (EIF2B5) p.Arg113His/p.256_281del 40 ± 2
571-1 c.166T > G/c.944G > A (EIF2B5) p.Phe56Val/p.Arg315His 40 ± 3
357-2 c.406C > T/c.1015C > T(EIF2B5) p.Arg136Cys/p.Arg339Trp 44.5 ± 4.5
1078-1 c.407G > A/c.407G > A (EIF2B5) p.Arg136His/p.Arg136His 49.6 ± 5.7
432-2 c.271A > G/c.1015C > T (EIF2B5) p.Thr91Ala/p.Arg339Trp 53.9 ± 0,.9
522-1 c.47C > A/c.338G > A (EIF2B5) p.Ala16Asp/p.Arg113His 54 ± 6
648-1* c.638A > G/c.638A > G (EIF2B2) p.Glu213Gly/p.Glu213Gly 59 ± 1
648-2* c.638A > G/c.638A > G (EIF2B2) p.Glu213Gly/p.Glu213Gly 64 ± 4
1014-1 c.338G > A/c.583C > T(EIF2B5) p.Arg113His/p.Arg195Cys 68 ± 4
338-1 c.338G > A/c.338G > A (EIF2B5) p.Arg113His/p.Arg113His 75.2 ± 1.5
370-2 c.338G > A/c.584G > A(EIF2B5) p.Arg113His/p.Arg195His 77 ± 2.5
630-1 c.338G > A/c.338G > A (EIF2B5) p.Arg113His/p.Arg113His 77.5 ± 2.5
1241-1* c.338G > A/c.338G > A (EIF2B5) p.Arg113His/p.Arg113His NA
807-1* c.338G > A/c.338G > A (EIF2B5) p.Arg113His/p.Arg113His 67 ± 4.3
The clinical and genetic status of these patients has previously been described [16]. Patients’ lymphoblasts were used to quantify the protein and transcript
expression of the ER-stress genes in comparison to associated controls. * Patients for whom ER-stress responses were compared between lymphoblasts and
lymphocytes.
NA: not available.
Table adapted from Horzinski et al. [16]
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Figure 1 Expression level of ATF4 protein and four mRNA markers of the ER-stress response in lymphoblasts from eIF2B-mutated
patients. (A) ATF4 protein induction (Western-blot); WT: control individuals; (+), (-): with or without 4 h thapsigargin (Tg) treatment. (B-E)
Expression levels of ATF4 (B), CHOP (C), ASNS (D) and GRP78 (E) mRNA determined by quantitative real-time polymerase chain reaction; from
eIF2B-mutated patients (non-stippled bars), control individuals (stippled bars); under normal conditions (white bars) or following 4 h Tg
treatment (grey bars); mean ∆Ct values: mean Ct values of genes of interest corrected for the Ct value of the b2M gene.
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expected significant increase in the level of ATF4,
CHOP, ASNS and GRP78 mRNAs was also observed,
which was similar in normal and eIF2B-mutated EIL,
confirming the comparable activation of the ER-stress
response in the two cell types (Figure 1B-E). An inter-
individual variability was high in stressed as well as non-
stressed cells, and no significant differences between
controls and patients were observed. Moreover, we did
not find any correlation between the rate of eIF2B GEF
activity and the level of ATF4 translational induction or
transcriptional activation of ATF4, CHOP, ASNS and
GRP78. Likewise, other ER-stress conditions (0.5 or 1
μg/ml Tg for 4 h or 1.5 h) before or after different
recovery times (1 h, 3 h, 6 h, 12 h, 15 h, 18 h and 24 h)
did not result in any significant difference in the inten-
sity of the stress response between eIF2B-mutated and
non-mutated EIL (data not shown).
Effect of the EBV immortalization on the ER-stress
response mediated by ATF4
As primary eIF2B-mutated fibroblasts exhibit heightened
ER-stress response mediated by hyper-induction of
ATF4 [6], a possible explanation for the lack of differ-
ence between eIF2B-mutated and normal EIL on the
ER-stress activation could be the immortalization of the
PL by EBV. Therefore, we evaluated the impact of EBV
immortalization on ER-stress response by comparing
EIL and PL from four eIF2B-mutated patients (Table 1)
and three healthy individuals using the same stress
induction procedure. We found an expected increase in
the level of ATF4, CHOP, ASNS and GRP78 mRNA in
all the cells, but it was more profound in PL (Figure 2).
No significant differences were found in the activation
of ER-stress response between eIF2B-mutated and con-
trol PL, as was demonstrated in EIL (Figure 1), and
extended here to PL (Figure 2). Therefore, modifications
induced by EBV-immortalization of PL are not responsi-
ble for the absence of differential ER-stress response
between eIF2B-mutated and control cells.
Together, these results show that the eIF2B-mutated
EIL or PL do not differ from normal cells in their ATF4-
mediated ER-stress response induced by Tg despite the
low eIF2B GEF activity found in mutated EIL.
Discussion
In the present study, we evaluated the ER-stress
response pathway mediated by ATF4 in eIF2B-mutated
EIL in comparison to control cells. Our results con-
firmed that eIF2B activity was reduced in mutated EIL,
but without significant hyperactivation of the UPR path-
way. However, an abnormal heightened stress response
was identified earlier in patients’ brains [13] and in pri-
mary fibroblasts [9]. Cells from the same four patients
(1048-1, 432-2, 522-1 and 1241-1) were analysed in this
study and in the Kantor et al. paper [9]. We previously
demonstrated that transformation of primary fibroblasts
from eIF2B-mutated patients by SV40 large-T antigen
abolished the heightened stress response identified in
eIF2B-mutated compared to normal fibroblasts [9].
Accordingly, we anticipated that EBV-transformation may
abolish the possible hyper-sensitivity of eIF2B-mutated
lymphocytes to ER-stress agents. EBV-transformation
activates cyclin D2 and additional proteins involved in
cell cycle progression, including E2Fs, pRb and BCL-2,
reflecting cellular resistance to apoptosis [20]. More-
over, lymphoblasts have a modified metabolism
towards an anti-apoptotic phenotype, exerted by EBV
antigen 3A (EBNA3A)-mediated induction of protective
chaperones and co-chaperones such as Hsp70 [21]. In
contrast to our prediction, we found that EBV-trans-
formation of PL is not responsible for the absence of
the anticipated heightened ER-stress response of
eIF2B-mutated compared to control PL. However,
EBV-transformation did reduce the strength of the ER-
stress response in both cell types, as demonstrated by
the higher induction of ATF4 and GRP78 in PL com-
pared to EIL (Figure 2).
Our data are in agreement with results of van Kollen-
burg et al [17], who studied stress-related differences
between eIF2B-mutated and normal lymphoblasts after
heat shock and who found a lesser increase in eIF2a
phosphorylation in patients’ EIL in response to the heat-
shock. Although the experimental variables involved in
the current study do not allow to reproducibly pick
subtle changes in eIF2a phosphorylation level, even a
slight eIF2a hypo-phosphorylation response may explain
the absence of heightened ER-stress response in eIF2B-
mutated PL and EIL used here. None of the mutations
studied here correspond to mutations in yeast previously
shown to render eIF2B resistant to the effects of eIF2a
phosphorylation [10,11,15]. Immortalization of mouse
fibroblasts was found to increase eIF2B expression lead-
ing to increased GEF activity and to reduced sensitivity
to eIF2 phosphorylation [22]. We therefore hypothesize
that eIF2 expression is increased in EIL in comparison
to PL, making i) the GEF assay more robust in EIL in
which differences in GEF activity between control and
eIF2B-mutated patients are more easily discerned, and
ii) EIL are less sensitive to increased eIF2 phosphoryla-
tion following UPR in comparison to PL [22]. Further
analyses are needed to determine if the normal ER-stress
response found in eIF2B-mutated EIL despite a low
eIF2B GEF activity is also a trait of other non-trans-
formed, yet actively dividing eIF2B-mutated cells during
the course of development. This could contribute to the
observation of a cell fate impairment restricted to glial
cell development in the large majority of eIF2B-mutated
patients [23].
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Figure 2 Effect of the lymphocytes EBV-transformation on the expression level of the four mRNA markers of the ER-stress response.
Thapsigargin (incubation with Thapsigargin (Tg) at 2 μg/ml for 4 h) was used to induce ER-stress in lymphoblastoid cell lines (EIL, black bars)
and primary lymphocytes (PL, white bars) from control (C1, C2 and 1283-1) and eIF2B-mutated (1241-1, 807-1, 648-1 and 648-2) patients.
Expression levels of ATF4 (A), GRP78 (B), ASNS (C) and CHOP (D) mRNA were determined by quantitative real-time polymerase chain reaction. The
level of each transcript was calculated using the 2^(-∆∆Ct) method, followed by normalization of the primary Ct data to beta2M level. Results are
shown as fold-change between ER-stress (Tg incubation) compared to normal conditions.
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Conclusions
Lymphoblasts generated from patients’ blood samples
demonstrated a decrease in eIF2B GEF activity, a test
already proposed for the diagnostic screening and prog-
nosis of eIF2B-related disorders. However, measurement
of EIL and PL ER-stress response did not show any dif-
ferences between eIF2B-mutated and control cells and
therefore is not useful as a supplementary test to
improve diagnosis.
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